MSB 2.11% 97.0¢ mesoblast limited

Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-367

  1. 4,687 Posts.
    lightbulb Created with Sketch. 169
    I am a big believer in MSB and stem cell therapy ... but I also don't trust the FDA to do the right thing ... remember how long a what a fight for VCR ... they lost!
    how about AVH ... stymied for 15 years or more ... and now MSB with a sensational product for COVID 19 and still not approved for emergencies except in a trial ... which , In my opinion, may get orphan status and not full approval ... too much potential losses for big pharma ... just my humble opinion .. maybe down the road approval ... maybe a takeover to control its usage ... I don't know but certainly do t trust FDA and certainly not with Trump in power
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
0.020(2.11%)
Mkt cap ! $1.107B
Open High Low Value Volume
94.5¢ 98.0¢ 93.5¢ $3.680M 3.810M

Buyers (Bids)

No. Vol. Price($)
5 149921 96.5¢
 

Sellers (Offers)

Price($) Vol. No.
97.5¢ 60000 1
View Market Depth
Last trade - 16.10pm 12/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.